Canada launched Health Emergency Readiness Canada in September 2024 to coordinate development and production of vaccines, therapeutics, diagnostics and other medical countermeasures. The federal agency was designed to close gaps exposed when COVID-19 created urgent global competition for research, manufacturing and supplies.
HERC sits within the industry department
The organization was established as a special operating agency within Innovation, Science and Economic Development Canada. It works with Health Canada, the Public Health Agency of Canada and other partners.
That structure emphasizes industrial readiness while regulators and public-health officials retain distinct responsibilities.
The mandate spans research to manufacturing
Canada has strong laboratory and university science, but promising products can fail to reach clinical testing or commercial scale. HERC aims to connect those stages and maintain capacity before an emergency.
A facility that exists on paper still needs trained staff, validated processes and supply contracts to respond quickly.
Vaccines are one part of preparedness
Headlines emphasized faster vaccines, but diagnostics, antiviral or other treatments, protective equipment and platform technologies also matter. Different threats require different combinations of countermeasures.
Investing in adaptable platforms may reduce response time when the exact next pathogen is unknown.
Coordination can prevent fragmented spending
Multiple departments, provinces, companies and research funders made pandemic decisions under pressure. A focal point can map capacity, identify gaps and maintain an industrial mobilization plan.
Central coordination should not suppress independent scientific advice or provincial operational knowledge.
Canada looked to international models
The government compared HERC with the United States’ BARDA and the European Union’s HERA. Those institutions use procurement and partnerships to move priority countermeasures toward readiness.
Canada needed a model suited to its smaller market while cooperating with allies rather than pursuing complete self-sufficiency.
Readiness requires work between emergencies
Manufacturing lines, stockpiles and clinical-trial networks can deteriorate when immediate demand disappears. Long-term contracts and exercises may preserve capability, but they must deliver public value.
Expiry, maintenance and workforce retention belong in the true cost of preparedness.
Transparency protects trust
Emergency procurement can involve large contracts and commercial confidentiality. HERC should publish selection criteria, milestones, conflicts and performance while protecting genuinely sensitive information.
Failed research is sometimes unavoidable; unexplained spending and political favouritism are not.
Speed cannot remove safety standards
Faster development can come from prepared platforms, parallel planning and early manufacturing, not from ignoring evidence. Health Canada still must assess quality, safety and effectiveness.
HERC’s success would be measured by time to validated products, reliable domestic capacity and equitable access during a real emergency. The agency created a framework; sustained expertise, oversight and practice would determine whether Canada was genuinely better prepared.
Preparedness plans should include Indigenous and remote communities, whose supply constraints may appear before those in major cities. Contracts can require scalable packaging, cold-chain options and allocation rules in advance. Regular public exercises would expose gaps while they were still correctable. Canada also needed international data sharing because pathogens cross borders and no national manufacturing strategy can replace rapid access to global surveillance.
Results from those exercises should be published with deadlines for correction.
